Evolent Health Inc.

NYSE: EVH · Real-Time Price · USD
9.22
0.40 (4.54%)
At close: Aug 15, 2025, 2:57 PM

Evolent Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-161.65M -108.96M -61.62M -72.23M -74.42M -110.34M -113.04M -90.98M -63.53M -33.8M -19.16M -13.46M -28.63M -33.14M -37.6M -45.76M -70.89M -265.3M
Depreciation & Amortization
112.27M 121M 124.05M 120.67M 123.38M 123.64M 125.7M 115.88M 100.68M 83.65M 67.19M 62.33M 59.99M 59.8M 60.04M 59.99M 59.82M 60.68M
Stock-Based Compensation
19.38M 32.04M 39.75M 56.46M 52.27M 48.58M 40.5M 44.53M 41.3M 39.34M 33.98M 24.31M 21.71M 18.35M 16.71M 15.98M 14.75M 14.8M
Other Working Capital
-192.1M -119.12M -157.55M 24.03M 89.63M 190.25M 232.94M 176.31M 133.95M 87.76M 3.82M -83.04M -149.47M -96.67M -1M 1.65M -16.94M -43.59M
Other Non-Cash Items
133.92M 78.48M 35.96M 72.55M 82.44M 98.78M 119.11M 57.41M 33.27M 16.87M 2.01M 20.29M 36.07M 35.45M 13.77M 14.92M 39.69M 235.39M
Deferred Income Tax
-2.58M -2.88M -2.82M -21M -27.24M -28.37M -97.46M -74.34M -71.15M -68.25M 342K -3.75M 214K -599K -526K -647K -508K -1.25M
Change in Working Capital
-134.68M -101.26M -116.56M -22.08M 19.8M 23.18M 67.77M 36.39M -24.46M -8.71M -104.72M -79.11M -21.98M -50.39M -13.64M -85.25M -148.63M -88.18M
Operating Cash Flow
-33.33M 18.42M 18.77M 134.38M 176.23M 155.47M 142.58M 88.9M 24.91M 37.91M -11.55M 19.41M 67.38M 29.47M 38.75M -40.76M -105.76M -43.85M
Capital Expenditures
-29.8M -28.14M -24.89M -24.79M -25.3M -25.04M -28.75M -33.44M -36.52M -38.91M -38.36M -34.86M -31.21M -27.55M -24.98M -23.6M -23.53M -28.01M
Cash Acquisitions
-45.6M 1.38M -1K n/a -5.95M -2.91M -388.25M -386.87M -622.82M -619.5M -230.4M -278.9M -38.52M -40.32M -34.79M 12.03M 7.6M 7.6M
Purchase of Investments
-3.44M -4.32M -7.32M -7.32M -4.88M -1.49M 387.45M 405.19M 405.19M 385.94M n/a -17.75M -17.75M -1K -3M -3M -12.72M -12.83M
Sales Maturities Of Investments
781K n/a n/a n/a 78K 84K 870K 2.25M 2.18M 3.96M 5.55M 58.54M 63.39M 61.59M 59.71M 7.88M 140.84M 143.32M
Other Investing Acitivies
-35.22M -35.22M -30.72M -16.94M 577K -932K -386.87M -401.08M -642.6M -634.14M -225.31M -265.46M -28.43M -35.38M -11.79M 43.98M 207.64M 207.75M
Investing Cash Flow
-113.28M -66.29M -62.93M -49.05M -35.47M -30.28M -415.54M -413.95M -662.79M -670.87M -259.12M -309.03M -55.84M -44.97M -15.79M 36.36M 319.83M 317.83M
Debt Repayment
217.6M 217.6M 58.58M -25.8M -35.8M -36.07M 183.29M 208.56M 438.3M 438.57M 219.74M 219.74M n/a n/a n/a -218K -218K -218K
Common Stock Repurchased
-5.59M -5.96M -15.7M -15.39M -14.7M -14.47M -12.74M -13.64M -14.59M -14.71M -18.32M -17.87M -17.18M -17.38M -3.85M -3.87M -3.66M -3.35M
Dividend Paid
-14.52M -19.58M -20.09M -20.44M -20.4M -20.22M -18.79M -28.52M -23.42M -32.32M -29.77M -14.88M -14.88M -2.4M -1.3M -1.3M -1.3M n/a
Other Financial Acitivies
-13.98M -103.42M -42.52M -138.14M -152.59M -25.73M -50.19M -8.07M -37.03M -31.04M -76.29M -4.08M 46.19M -22.49M -27.8M -112.84M -127.29M -99.75M
Financial Cash Flow
186.86M 92.41M -565K -181.86M -210.22M -83.51M 281.34M 354.84M 565.29M 562.65M 131.54M 203.29M 30.85M -25.34M -29.55M -114.36M -128.86M -100.02M
Net Cash Flow
52.47M 44.46M -44.87M -96.56M -69.56M 41.51M 8.3M 29.68M -72.83M -70.82M -139.78M -86.94M 42.02M -40.98M -6.62M -118.78M 85.22M 173.99M
Free Cash Flow
-63.13M -9.72M -6.13M 109.58M 150.93M 130.43M 113.84M 55.46M -11.61M -993K -49.91M -15.45M 36.16M 1.92M 13.76M -64.36M -129.29M -71.86M